• The Journal of Clinical Hypertension (Greenwich). 2009;11(4):207–213.
Results of Treatment With Telmisartan‐Amlodipine in Hypertensive Patients
Thomas W. Littlejohn, III, MD; Claudio R. Majul, MD; Rafael Olvera, MD; Mary Seeber, MD; Maureen Kobe, MSc; Robert Guthrie, MD; Wille Oigman, MD; On behalf of the study investigators
Section B of Figure 2 appearing on page 211 was missing Baseline SBP (mm Hg) data on the x‐axis. The correct figure is printed below:
Figure 2.
Effect of 8 weeks of treatment with the combinations of telmisartan 40 or 80 mg plus amlodipine 5 or 10 mg on the change from baseline in the in‐clinic trough [A] diastolic blood pressure (mm Hg) or [B] systolic blood pressure (mm Hg) according to baseline blood pressure categories. DBP, diastolic blood pressure; SBP, systolic blood pressure; A5, amlodipine 5 mg; A10, amlodipine 10 mg; T40, telmisartan 40 mg; T80, telmisartan 80 mg.